RT Journal Article
SR Electronic
T1 Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e005640
DO 10.1136/jitc-2022-005640
VO 11
IS 2
A1 Monge, Cecilia
A1 Xie, Changqing
A1 Myojin, Yuta
A1 Coffman, Kelley
A1 Hrones, Donna Mabry
A1 Wang, Sophie
A1 Hernandez, Jonathan M
A1 Wood, Bradford J
A1 Levy, Elliot B
A1 Juburi, Israa
A1 Hewitt, Stephen M
A1 Kleiner, David E
A1 Steinberg, Seth M
A1 Figg, William D
A1 Redd, Bernadette
A1 Homan, Philip
A1 Cam, Maggie
A1 Ruf, Benjamin
A1 Duffy, Austin G
A1 Greten, Tim F
YR 2023
UL http://jitc.bmj.com/content/11/2/e005640.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.